Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data
2016 ◽
Vol 19
(5)
◽
pp. 515-525
◽
2012 ◽
Vol 13
(18)
◽
pp. 2711-2715
◽
Keyword(s):
2014 ◽
Vol 69
(10)
◽
pp. 2835-2840
◽
2020 ◽
Vol 54
(9)
◽
pp. 939-940
◽
Keyword(s):
2018 ◽
Vol 17
(3)
◽
pp. 215-222.e3
◽
2012 ◽
Vol 38
(11)
◽
pp. 1804-1811
◽